Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
about
Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case reportBMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy.New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation.Transplantation-associated thrombotic microangiopathy: twenty-two years later.Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria.Thrombotic microangiopathy in haematopoietic cell transplantation: an update.Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.Raiders of the lost mark - endothelial cells and their role in transplantation for hematologic malignancies.
P2860
Q31152215-147059C9-FABD-4E14-83EF-CAAA2C468394Q33328421-3079C38A-ABD3-40E4-BB75-BEC0A0DF21E1Q33337686-9B7CDAF3-983E-438E-BA5D-AC297E6639D6Q33339749-B16EF6E6-EDEE-4521-B69B-B467B66F9E08Q33342975-2F1A6D2A-F432-4DD8-B24E-967C840FC3FEQ33345369-AA65F50B-0E8B-4698-9A28-9EE54740EA78Q33359551-5B7E0460-DA38-427D-B214-5E495469646DQ33382787-8B9F02B0-7A5B-4C45-B7F1-468F1E84BE1AQ33847973-3D46565A-0649-4030-9F9E-2C3A393C8856Q34085681-9D2CF934-626A-4C20-9BA7-2535AC93FBCBQ35098992-8527C1D9-87BE-4FD1-9737-0E76A567C5E0Q35934133-3EDAD6EB-FCC6-4760-B916-894DCB8BEB17Q36313028-21549FDD-BFF9-4231-AE52-12DB81D68BF1Q36585425-A942703B-EB9F-4A34-BCF6-08054C08DFB3Q51651776-8C13C357-B0D1-483E-A761-9C79BFC2AD21
P2860
Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@ast
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@en
type
label
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@ast
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@en
prefLabel
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@ast
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@en
P2093
P1476
Plasma von Willebrand Factor A ...... otic microangiopathy (BMT-TM).
@en
P2093
Andrews DF 3rd
Nemunaitis J
Raymond JM
Rintels PB
Rosenfeld CS
Shadduck RK
P304
P356
10.1002/(SICI)1096-8652(199612)53:4<213::AID-AJH1>3.0.CO;2-0
P577
1996-12-01T00:00:00Z